• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性进行性言语失用症患者的死因。

Cause of death for patients who present with primary progressive apraxia of speech.

作者信息

Utianski Rene L, Meade Gabriela, Duffy Joseph R, Boland Sarah, Whitwell Jennifer L, Botha Hugo, Josephs Keith A

机构信息

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

出版信息

Parkinsonism Relat Disord. 2025 Jul 21;138:107968. doi: 10.1016/j.parkreldis.2025.107968.

DOI:10.1016/j.parkreldis.2025.107968
PMID:40706471
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12349914/
Abstract

BACKGROUND

Apraxia of speech (AOS) can be the initial and sole manifestation of neurodegenerative diseases, termed primary progressive apraxia of speech (PPAOS). These patients frequently evolve to atypical parkinsonism. There is little information to inform end of life planning and expectations.

OBJECTIVE

This study explored causes of death in patients who presented with PPAOS.

METHODS

Data for 29 deceased PPAOS patients and for whom cause of death data were available were reviewed.

RESULTS

Median age at death was 76.25 years following a median disease duration of 9.78 years. Fifteen patients (52 %) succumbed to deterioration from the disease, ten (34 %) died from complications associated with dysphagia, and the remainder from a brain bleed associated with a fall (10 %) or medical aid in dying (3 %).

CONCLUSIONS

The findings inform counseling and underscore the need for comprehensive, interdisciplinary care addressing swallowing impairments and systemic disease to prevent or delay causes of death.

摘要

背景

言语失用症(AOS)可能是神经退行性疾病的首发且唯一表现,称为原发性进行性言语失用症(PPAOS)。这些患者常发展为非典型帕金森综合征。关于临终规划和预期的信息很少。

目的

本研究探讨了出现PPAOS的患者的死因。

方法

回顾了29例已故PPAOS患者且有死因数据的资料。

结果

中位病程9.78年后,中位死亡年龄为76.25岁。15例患者(52%)死于疾病恶化,10例(34%)死于吞咽困难相关并发症,其余死于跌倒相关脑出血(10%)或临终医疗协助(3%)。

结论

这些发现为咨询提供了依据,并强调需要全面的跨学科护理,以解决吞咽障碍和全身性疾病问题,预防或延迟死亡原因。

相似文献

1
Cause of death for patients who present with primary progressive apraxia of speech.原发性进行性言语失用症患者的死因。
Parkinsonism Relat Disord. 2025 Jul 21;138:107968. doi: 10.1016/j.parkreldis.2025.107968.
2
Word Count Matters: Features of Written Language Production in Progressive Apraxia of Speech with and without Agrammatism.字数很重要:伴有和不伴有语法缺失的进行性言语失用症中书面语言产生的特征。
Folia Phoniatr Logop. 2025 Jan 17:1-9. doi: 10.1159/000543607.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Incidence of Primary Progressive Apraxia of Speech and Primary Progressive Aphasia in Olmsted County, MN, 2011-2022.2011 年至 2022 年明尼苏达州奥姆斯特德县原发性进行性运动性构音障碍和原发性进行性失语症的发病率。
Neurology. 2024 Aug 27;103(4):e209693. doi: 10.1212/WNL.0000000000209693. Epub 2024 Jul 30.
5
Interventions for childhood apraxia of speech.儿童言语失用症的干预措施。
Cochrane Database Syst Rev. 2018 May 30;5(5):CD006278. doi: 10.1002/14651858.CD006278.pub3.
6
Clinical dimensions along the non-fluent variant primary progressive aphasia spectrum.非流利型原发性进行性失语症谱中的临床维度。
Brain. 2024 Apr 4;147(4):1511-1525. doi: 10.1093/brain/awad396.
7
Delayed progressive apraxia of speech: A novel clinical entity distinct from primary progressive aphasia - A descriptive case series.迟发性进行性言语失用症:一种与原发性进行性失语症不同的新型临床实体——描述性病例系列
J Neurol Sci. 2025 Sep 15;476:123602. doi: 10.1016/j.jns.2025.123602. Epub 2025 Jul 8.
8
Supporting safe swallowing of care home residents with dysphagia: How does the care delivered compare with guidance from speech and language therapists?支持吞咽困难的养老院居民安全吞咽:提供的护理与言语治疗师的指导相比如何?
Int J Lang Commun Disord. 2024 Jul-Aug;59(4):1478-1488. doi: 10.1111/1460-6984.13015. Epub 2024 Jan 23.
9
Interventions for dysphagia in long-term, progressive muscle disease.长期进行性肌肉疾病吞咽困难的干预措施。
Cochrane Database Syst Rev. 2016 Feb 9;2(2):CD004303. doi: 10.1002/14651858.CD004303.pub4.
10
Solid Medication Intake in Hospitalised Patients With Dysphagia: A Challenge for Speech and Language Pathologists?吞咽困难住院患者的固体药物摄入:言语和语言病理学家面临的挑战?
Int J Lang Commun Disord. 2025 Jul-Aug;60(4):e70073. doi: 10.1111/1460-6984.70073.

本文引用的文献

1
Dysphagia and Mortality Risk in Individuals With Primary Progressive Apraxia of Speech.原发性进行性言语失用症患者的吞咽困难与死亡风险
Ann Clin Transl Neurol. 2025 Apr 24;12(7):1493-8. doi: 10.1002/acn3.70056.
2
Management and Treatment for Dysphagia in Neurodegenerative Disorders.神经退行性疾病吞咽困难的管理与治疗
J Clin Med. 2023 Dec 27;13(1):156. doi: 10.3390/jcm13010156.
3
Clinical course of pathologically confirmed corticobasal degeneration and corticobasal syndrome.经病理证实的皮质基底节变性和皮质基底节综合征的临床病程。
Brain Commun. 2023 Nov 3;5(6):fcad296. doi: 10.1093/braincomms/fcad296. eCollection 2023.
4
Longitudinal characterization of patients with progressive apraxia of speech without clearly predominant phonetic or prosodic speech features.无明显优势音系或韵律语音特征的进行性言语失用症患者的纵向特征。
Brain Lang. 2023 Oct;245:105314. doi: 10.1016/j.bandl.2023.105314. Epub 2023 Aug 20.
5
Risk factors to mortality and causes of death in frontotemporal dementia: An Australian perspective.额颞叶痴呆的死亡风险因素及死因:澳大利亚视角
Int J Geriatr Psychiatry. 2021 Dec 17;37(2). doi: 10.1002/gps.5668.
6
Survival in the Three Common Variants of Primary Progressive Aphasia: A Retrospective Study in a Tertiary Memory Clinic.原发性进行性失语三种常见变异型的生存情况:在三级记忆诊所的一项回顾性研究。
Brain Sci. 2021 Aug 24;11(9):1113. doi: 10.3390/brainsci11091113.
7
A molecular pathology, neurobiology, biochemical, genetic and neuroimaging study of progressive apraxia of speech.进行性言语失用症的分子病理学、神经生物学、生物化学、遗传学和神经影像学研究。
Nat Commun. 2021 Jun 8;12(1):3452. doi: 10.1038/s41467-021-23687-8.
8
Preferences for Communication About End-of-Life Care in Atypical Parkinsonism.非典型帕金森病患者对终末期医疗关怀沟通的偏好。
Mov Disord. 2021 Sep;36(9):2116-2125. doi: 10.1002/mds.28633. Epub 2021 Apr 28.
9
Frontotemporal Lobar Degeneration TDP-43-Immunoreactive Pathological Subtypes: Clinical and Mechanistic Significance.额颞叶变性 TDP-43 免疫反应性病理亚型:临床和机制意义。
Adv Exp Med Biol. 2021;1281:201-217. doi: 10.1007/978-3-030-51140-1_13.
10
Management of Dysphagia in Patients with Parkinson's Disease and Related Disorders.帕金森病及相关疾病患者吞咽困难的管理
Intern Med. 2020 Jan 1;59(1):7-14. doi: 10.2169/internalmedicine.2373-18. Epub 2019 Apr 17.